Whiskey and Health: Scoping Review with ☸️SAIMSARA.

Name: SAIMSARA Evidence Object longevity::WHISKEY_PM
Creator: SAIMSARA
License: https://saimsara.com/license/

SAIMSARA

doi:10.62487/saimsarab2bb44ca

SAIMSARA Journal

Machine-Readable Science • ISSN 3054-3991

Whiskey and Health: Scoping Review with ☸️SAIMSARA.

Longevity & Public Health

Issue 2, Volume 1, 2026

Chat with this issue

DOI: 10.62487/saimsarab2bb44ca

Editorial note

• Last update: 2026-04-26 11:52:11

What is this paper about

Whiskey is not simply “alcohol in a glass”: this review maps a striking split between oak-derived congeners with measurable antioxidant, metabolic, and gastroprotective signals, and clear ethanol-related risks including arrhythmia, mucosal injury, pregnancy-related developmental harm, and upper aerodigestive cancer. The full paper is worth reading because it separates biomarker-level promise from clinically relevant harm, showing where whiskey differs mechanistically from beer or wine — and where those differences still do not prove real-world health benefit.

Human-verified editorial review Verified by World ID proof-of-human. This editorial layer was submitted from a SAIMSARA account verified as a unique human.

Abstract: The aim of this paper is to synthesize the available experimental and observational evidence regarding the impact of whiskey consumption on human health, focusing on its antioxidant properties, metabolic effects, cardiovascular risks, and toxicological profile. The review utilises 452 original studies with 1309980 total participants (topic deduplicated ΣN). Across the mapped evidence, whiskey emerges as a beverage with a sharply divided health signal: oak-maturation congeners such as ellagic acid, gallic acid, and lyoniresinol show reproducible antioxidant, cytoprotective, and gastroprotective activity and were associated with a 17.5% increase in ABCA1-dependent cholesterol efflux and an approximately 11% rise in adiponectin in controlled trials, whereas acute and heavy intake was linked to atrial arrhythmia triggering at 60–120 mL doses, hyperhomocysteinemia (odds ratio 2.58), and markedly elevated esophageal cancer risk (odds ratio 28.7) in head-and-neck cancer patients. The dominant topics indicate that beverage matrix and congener content modify ethanol-related effects on gastric secretion, urate handling, endothelial function, and gut microbiome composition, suggesting whiskey is not interchangeable with other alcoholic beverages in mechanistic terms. Recurrent signals around mucosal injury, dental erosion, hormonal disruption, pregnancy-related developmental risk, and contamination of moonshine or flavored products reinforce that risk is greatest in heavy, adulterated, or vulnerable-host exposures, while any maturation-linked benefits remain clinically unproven. Clinically, these findings support counseling patients with arrhythmia susceptibility or upper aerodigestive cancer risk to avoid whiskey while recognizing its pragmatic role as an emergency oral ethanol source in ethylene glycol poisoning when standard antidotes are unavailable. The mapped evidence is dominated by small acute human studies and preclinical work, which limits causal interpretation. Future research should prioritize adequately powered longitudinal human trials that disentangle congener-specific bioactivity from ethanol effects, particularly for cholesterol efflux, adiponectin signaling, and microbiome modulation, to clarify whether any maturation-linked benefits are clinically meaningful at population-relevant intake levels.

Keywords: Whisky congeners; Alcohol Intake; Antioxidant capacity; Maturation age; GABA(A) receptor potentiation; Ethanol metabolism; Gastric mucosal protection; Polyphenols; Melanogenesis inhibition; Urate excretion; Allergic reaction suppression

Review Stats

Final search date and database lock: 2026-04-26 12:39:25 CEST
Plan: Pro (expanded craft tokens; source: PubMed)
Source: PubMed
Total Abstracts/Papers: 760
Downloaded Abstracts/Papers: 760
Included original and non-original Abstracts/Papers (all): 474
Included original Abstracts/Papers (Vote counting by direction of effect): 452
Reference Index (links used in paper): 155
Total participants (topic deduplicated ΣN): 1309980

Get access to the full paper

Unlock the full evidence map

Full paper access includes the complete human-readable review, figures, reference index, PDF export, and machine-readable Evidence JSON download.
Evidence JSON can also be purchased separately if you only need the LLM-ready object for agent, AI, or RAG workflows.
Institutional or library access? Sign in with your institution email to open all available SAIMSARA papers under your institution access arrangement.
Need a SAIMSARA review on your own topic? ☸️Request.

Reference Index (155)

[1] Induction of heme oxygenase-1 by whisky congeners in human endothelial cells. — https://doi.org/10.1111/j.1750-3841.2010.01697.x
[2] Aging of whiskey increases the potentiation of GABA(A) receptor response. — https://doi.org/10.1021/jf030111s
[3] Aromas Influencing the GABAergic System. — https://doi.org/10.3390/molecules27082414
[4] Effect of whiskey on atrial vulnerability and "holiday heart". — https://doi.org/10.1016/s0735-1097(83)80195-8
[5] Inhibitory effects of whisky polyphenols on melanogenesis in mouse B16 melanoma cells. — https://doi.org/10.1271/bbb.100514
[6] Profile of non-volatiles in whisky with regard to superoxide dismutase activity. — https://doi.org/10.1016/j.jbiosc.2011.04.002
[7] Protective effects of the whisky congeners on ethanol-induced gastric mucosal damage. — https://doi.org/10.1111/j.1530-0277.2006.00319.x
[8] Reactive oxygen scavenging activity of matured whiskey and its active polyphenols. — https://doi.org/10.1111/j.1750-3841.2007.00311.x

Unlock the full paper to view the complete Reference Index.